FIRM FAVOURITE

The results of 3D EMlift’s clinical trial were announced at a VIP event in London, proving the efficacy of the device for lifting, toning and firming

On April 24, the team from 3D Aesthetics was joined by cosmetic doctor Dr Abs Settipalli to present the results of a clinical trial on the brand’s latest device, the 3D EMlift. VIP guests, including press and clinic owners, attended this exclusive conference. The day consisted of a series of presentations from key industry leaders and renowned aesthetics experts Dr Settipalli and Dr Jonquille Chantrey.

In his presentation, Dr Settipalli emphasised a need for a holistic approach to anti-ageing and expressed his reservations on the overreliance on botulinum toxin, saying: “The first response to a patient wanting to have anti-ageing treatment or look better should not be a toxin.” He highlighted the adverse effects of repeated and inappropriate use of botulinum toxins, citing independent studies, and presented evidence of the negative consequences of toxin injections on skin quality, showcasing data that demonstrated deterioration in elasticity and firmness.

“What it actually showed us was that the elasticity and things like firmness completely deteriorate afterwards. Now, you may get some reduction of wrinkles and lines, I’m not saying you won’t, we’ve all seen the effects of botulinum toxin, but repeated and inappropriate use shows that these are the negative consequences,” said Dr Settipalli, who argued for a shift towards non-invasive technologies that focus on improving skin quality rather than solely targeting muscular movement.

“If you reach for technologies like 3D EMlift, you enhance the quality of skin; you improve tissues as early as possible. There is no need to go for botulinum toxin because movement is not necessarily what causes wrinkles.”

He added, “I was behind the trial to find the data as to what it does to our skin, especially relative to things like toxin. What we found was that it makes the skin much, much firmer, very, very quickly, which is the opposite of what we see with toxin when compared to previous data.”

The clinical trial results showcased significant improvements, including:

• 100% firmer skin

• 94% visible lift

• 94% fewer wrinkles

• 82% increase in muscle tone, with immediate changes observed.

“The point of this study is to realise that you shouldn’t jump to injectables every single time, and there’s much more to it. Combination therapy is key, especially using technology like the 3D EMlift,” added Dr Settipalli.

After Dr Settipalli’s insightful talk, Dr Jonquille Chantrey, founder of ØNE aesthetic studiø in Cheshire, took to the stage to share her perspective as an expert in aesthetic medicine. She emphasised the versatility and effectiveness of 3D EMlift, which she offers at her clinic.

She also talked about the benefits of combining the device with other therapies to enhance overall outcomes and patient satisfaction, emphasising celebrities who had adopted 3D EMlift, including Sally Dynevor , Helen Skelton, and Samia Longchambon, who tried the treatment at her clinic, citing impressive results.

“For the patients that were concerned about crow’s feet lines, forehead lines and mid facial volume deficit... If they’re nervous about other types of procedures, [3D EMlift] is a great starting point. It’s painless and there’s no downtime... In my practice, the top patient reported outcome of this procedure was that they were satisfied with the definition,” said Dr Chantrey.